Pathogenesis, epidemiology and control of Group A Streptococcus infection

Streptococcus pyogenes (Group A Streptococcus; GAS) is exquisitely adapted to the human host, resulting in asymptomatic infection, pharyngitis, pyoderma, scarlet fever or invasive diseases, with potential for triggering post-infection immune sequelae. GAS deploys a range of virulence determinants to...

Full description

Saved in:

Bibliographic Details
Published in:	Nature reviews. Microbiology Vol. 21; no. 7; pp. 431 - 447
Main Authors:	Brouwer, Stephan, Rivera-Hernandez, Tania, Curren, Bodie F, Harbison-Price, Nichaela, De Oliveira, David M P, Jespersen, Magnus G, Davies, Mark R, Walker, Mark J
Format:	Journal Article
Language:	English
Published:	England Nature Publishing Group 01.07.2023
Subjects:	Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotics Asymptomatic infection Bacteria Complications Disease transmission Drug resistance Drug Resistance, Bacterial Epidemiology Humans Immune response Macrolides - pharmacology Macrolides - therapeutic use Molecular modelling Pathogenesis Penicillin Penicillins - therapeutic use Pharyngitis Pyoderma Scarlet fever Streptococcal Infections - drug therapy Streptococcal Infections - epidemiology Streptococcal Infections - prevention & control Streptococcus Streptococcus infections Streptococcus pyogenes - genetics Vaccines Virulence
ISSN:	1740-1526, 1740-1534, 1740-1534
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!